Prawo i regulacje · 28/01/2003
MDI Pharmaceuticals Revokes FDA Registration, Citing 'Unacceptable' Inspection Findings
MDI Pharmaceuticals has revoked its FDA registration, citing 'unacceptable' inspection findings, marking the latest development in the company's struggles with regulatory compliance